Lavori scientifici (bibliografia)

maggio 16th, 2011 Presentazione Prof Dott Enrico Roda 0 Comments

  1. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease.

Lanzoni G, Alviano F, Marchionni C, Bonsi L, Costa R, Foroni L, Roda G, Belluzzi A, Caponi

A, Ricci F, Luigi Tazzari P, Pagliaro P, Rizzo R, Lanza F, Roberto Baricordi O, Pasquinelli G, Roda E, Paolo Bagnara G.

Cytotherapy. 2009;11(8):1020-31.

  1. G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence.

Lodato F, Azzaroli F, Tamè MR, Di Girolamo M, Buonfiglioli F, Mazzella N, Cecinato P, Roda E, Mazzella G.

World J Gastroenterol. 2009 Nov 21;15(43):5449-54.

  1. Pilot study: the use of sulfasalazine for the treatment of acute pouchitis.

Belluzzi A, Serrani M, Roda G, Bianchi ML, Castellani L, Grazia M, Rosati G, Ugolini G, Roda E.

Aliment Pharmacol Ther. 2010 Jan 15;31(2):228-32.

  1. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.

Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, Grazi GL, Pinna AD, Andreone P, Bernardi M; Bologna Liver Transplantation Group.

J Clin Gastroenterol. 2010 Jan;44(1):52-7.

  1. Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.

Roda G, Caponi A, Belluzzi A, Roda E.

Dig Liver Dis. 2009 Dec;41(12):914-5.

  1. Generation of a novel antibody probe to the apical sodium-dependent bile acid transporter that inhibits ileal bile acid absorption.

Montagnani M, Marangoni A, Roda A, Azzaroli F, Mazzella G, Roda E, Tsivian M, Neri F, Jovani M, Giandinoto M, Caponi A, Aldini R.

Mol Pharm. 2009 May-Jun;6(3):1012-8.

  1. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations.

Caponi A, Lisotti A, Grenci C, Roda E.

Minerva Gastroenterol Dietol. 2008 Dec;54(4):331-4.

  1. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage.

Lisotti A, Grenci C, Caponi A, Roda E.

Minerva Gastroenterol Dietol. 2008 Dec;54(4):323-9.

  1. Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project).

Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Mazzella G, Sama C, Roda E, Colecchia A.

World J Gastroenterol. 2008 Sep 14;14(34):5282-9.

  1. Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP.

World J Gastroenterol. 2008 Aug 7;14(29):4616-26. Review.

  1. Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma.

Pastorini E, Locatelli M, Simoni P, Roda G, Roda E, Roda A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 1;872(1-2):99-106.

  1. Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.

Festi D, Montagnani M, Azzaroli F, Lodato F, Mazzella G, Roda A, Di Biase AR, Roda E, Simoni P, Colecchia A.

Curr Clin Pharmacol. 2007 May;2(2):155-77. Review.

  1. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.

Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE.

Am J Gastroenterol. 2008 Oct;103(10):2465-73.

  1. Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.

Lodato F, Berardi S, Gramenzi A, Mazzella G, Lenzi M, Morelli MC, Tame MR, Piscaglia F, Andreone P; Bologna Liver Transplantation Group (BLTG), Ballardini G, Bernardi M, Bianchi FB, Biselli M, Bolondi L, Cescon M, Colecchia A, D’Errico A, Del Gaudio M, Ercolani G, Grazi GL, Grigioni W, Lorenzini S, Pinna AD, Ravaioli M, Roda E, Sama C, Vivarelli M.

Aliment Pharmacol Ther. 2008 Aug 15;28(4):450-7.

  1. Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Lodato F, Azzaroli F, Di Girolamo M, Feletti V, Cecinato P, Lisotti A, Festi D, Roda E, Mazzella G.

World J Gastroenterol. 2008 May 21;14(19):2980-5. Review.

  1. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators.

Radaelli F, Meucci G, Sgroi G, Minoli G; Italian Association of Hospital Gastroenterologists (AIGO).

Am J Gastroenterol. 2008 May;103(5):1122-30.

  1. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study.

Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F.

Gut. 2008 Oct;57(10):1354-9.

  1. Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists.

Radaelli F, Meucci G, Minoli G; Italian Association of Hospital Gastroenterologists (AIGO).

Dig Liver Dis. 2008 Nov;40(11):897-904.

 

  1. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.

Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A.

Rapid Commun Mass Spectrom. 2007;21(24):4142-8

  1. Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid.

Azzaroli F, Mennone A, Feletti V, Simoni P, Baglivo E, Montagnani M, Rizzo N, Pelusi G, DE Aloysio D, Lodato F, Festi D, Colecchia A, Roda E, Boyer JL, Mazzella G.

Aliment Pharmacol Ther. 2007 Oct 15;26(8):1139-46

  1. Results of endoscopic retrograde cholangiopancreatography in the treatment of biliary tract complications after orthotopic liver transplantation: our experience.

Solmi L, Cariani G, Leo P, Miracolo A, Nigro G, Roda E.

Hepatogastroenterology. 2007 Jun;54(76):1004-8.

  1. Endoloop-assisted polypectomy for large peduncolated colorectal polyps.

Cariani G, Di Marco M, Roda E.

Surg Endosc. 2007 Sep;21(9):1676-7. No abstract available.

  1. A new iron free treatment with oral fish cartilage polysaccharide for iron deficiency chronic anemia in inflammatory bowel diseases: a pilot study.

Belluzzi A, Roda G, Tonon F, Soleti A, Caponi A, Tuci A, Roda A, Roda E.

World J Gastroenterol. 2007 Mar 14;13(10):1575-8.

  1. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon.

Roda A, Simoni P, Magliulo M, Nanni P, Baraldini M, Roda G, Roda E.

World J Gastroenterol. 2007 Feb 21;13(7):1079-84.

  1. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease.

Colecchia A, Vestito A, Pasqui F, Mazzella G, Roda E, Pistoia F, Brandimarte G, Festi D.

World J Gastroenterol. 2007 Jan 14;13(2):264-9.

  1. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas.

Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, Kang JY, Leicester RJ.

Int J Colorectal Dis. 2007 Jul;22(7):765-76.

  1. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.

Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E.

World J Gastroenterol. 2006 Dec 7;12(45):7239-49. Review.

 

  1. Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting.

Colecchia A, Sandri L, Bacchi-Reggiani ML, Portincasa P, Palasciano G, Mazzella G, Roda E, Festi D.

Am J Gastroenterol. 2006 Nov;101(11):2576-81; quiz 2672.

  1. Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent.

Lodato F, Tamé MR, Montagnani M, Sambri V, Liguori G, Azzaroli F, Costigliola P, Grazi G, Roda E, Mazzella G.

Liver Transpl. 2006 Nov;12(11):1711-4.

  1. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.

Zagari RM, Bianchi-Porro G, Fiocca R, Gasbarrini G, Roda E, Bazzoli F.

Gut. 2007 Apr;56(4):475-9.

  1. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.

Colecchia A, Mazzella G, Sandri L, Azzaroli F, Magliuolo M, Simoni P, Bacchi-Reggiani ML, Roda E, Festi D.

World J Gastroenterol. 2006 Sep 7;12(33):5336-43.

  1. Efficacy and safety of ERCP in patients 90 years of age and older.

Cariani G, Di Marco M, Roda E, Solmi L.

Gastrointest Endosc. 2006 Sep;64(3):471-2.

  1. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence.

Lodato F, Tame MR, Colecchia A, Racchini C, Azzaroli F, D’Errico A, Casanova S, Pinna A, Roda E, Mazzella G.

World J Gastroenterol. 2006 Jul 14;12(26):4253-5.

  1. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.

Azzaroli F, Colecchia A, Lodato F, Trerè D, Bacchi Reggiani ML, Festi D, Prati GM, Accogli E, Casanova S, Derenzini M, Roda E, Mazzella G.

Aliment Pharmacol Ther. 2006 Jul 1;24(1):129-36. Erratum in: Aliment Pharmacol Ther. 2006 Jul 15;24(2):439. Colecchi, A [corrected to Colecchia, A].

  1. Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy.

Baldi F, Cavoli C, Ghersi S, Mantovani L, Torresan F, Roda E.

Dig Liver Dis. 2006 Jul;38(7):452-8.

  1. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma.

Solmi L, Nigro G, Roda E.

World J Gastroenterol. 2006 Feb 21;12(7):1098-104.

  1. Management of hepatic encephalopathy: focus on antibiotic therapy.

Festi D, Vestito A, Mazzella G, Roda E, Colecchia A.

Digestion. 2006;73 Suppl 1:94-101.

  1. Endoscopic surveillance in Barrett’s esophagus.

Lunedei V, Bazzoli F, Pozzato P, De Luca L, Zagari RM, Fossi S, Ricciardiello L, Maltoni S, Roda E. Minerva Gastroenterol Dietol. 2002 Jun;48(2):63-71

  1. Cholic acid metabolism in human fecal cultures during diet supplementation with Lacto-bacillus rhamnosus GG]

Mirasoli M, Roda A, Montagnani M, Azzaroli F, Roda E.

Minerva Gastroenterol Dietol. 2002 Mar;48(1):45-9.

  1. Gallbladder cholesterol polyps and cholesterolosis.

Sandri L, Colecchia A, Larocca A, Vestito A, Capodicasa S, Azzaroli F, Mazzella G, Mwangemi C, Roda E, Festi D.

Minerva Gastroenterol Dietol. 2003 Sep;49(3):217-24.

  1. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.

Baldi F, Cappiello R, Cavoli C, Ghersi S, Torresan F, Roda E.

World J Gastroenterol. 2006 Jan 7;12(1):82-8.

  1. Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis.

Attili AF, De Santis A, Attili F, Roda E, Festi D, Carulli N.

World J Gastroenterol. 2005 Nov 7;11(41):6508-11

  1. 13C-urea breath test to assess Helicobacter pylori bacterial load.

Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G, Roda E, Bazzoli F.

Helicobacter. 2005 Dec;10(6):615-9.

  1. Hemoclips in massive bleeding after snare resection of a misleading polyp (appendiceal stump).

Cariani G, Roda E.

Surg Endosc. 2004 Nov;18(11):1686; author reply 1687. No abstract available.

  1. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man.

Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, Roda A.

Osteoarthritis Cartilage. 2005 Dec;13(12):1041-9. Epub 2005 Sep 13.

  1. Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study.

Lodato F, Azzaroli F, Brillanti S, Colecchia A, Tamé MR, Montagnani M, Muratori R, Giovanelli S, Feletti V, Bacchi Reggiani ML, Roda E, Mazzella G.

J Viral Hepat. 2005 Sep;12(5):536-42. Erratum in: J Viral Hepat. 2005 Nov;12(6):663

  1. Chemiluminescence quantitative immunohistochemical determination of MRP2 in liver biopsies.

Guardigli M, Marangi M, Casanova S, Grigioni WF, Roda E, Roda A.

J Histochem Cytochem. 2005 Dec;53(12):1451-7.

 

  1. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.

Ricciardiello L, Ceccarelli C, Angiolini G, Pariali M, Chieco P, Paterini P, Biasco G, Martinelli GN, Roda E, Bazzoli F.

Clin Cancer Res. 2005 Jun 1;11(11):4234-40.

  1. Measuring dyspepsia: a new severity index validated in Bologna.

De Luca L, Zagari RM, Pozzato P, Fiorini T, Ricciardiello L, Martuzzi C, Roda E, Bazzoli F, van Zanten SJ.

Dig Liver Dis. 2004 Dec;36(12):806-10.

  1. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Festi D, Capodicasa S, Sandri L, Colaiocco-Ferrante L, Staniscia T, Vitacolonna E, Vestito A, Simoni P, Mazzella G, Portincasa P, Roda E, Colecchia A.

World J Gastroenterol. 2005 Jan 7;11(1):142-8.

  1. Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis.

Azzaroli F, Accogli E, Nigro G, Trere D, Giovanelli S, Miracolo A, Lodato F, Montagnani M, Tamé M, Colecchia A, Mwangemi C, Festi D, Roda E, Derenzini M, Mazzella G.

World J Gastroenterol. 2004 Nov 1;10(21):3099-102.

  1. Breath tests with stable isotopes: have they a role in liver transplantation?

Festi D, Capodicasa S, Vestito A, Mazzella G, Roda E, Vitacolonna E, Petrolati A, Angelico M, Colecchia A.

Eur Rev Med Pharmacol Sci. 2004 Jan-Feb;8(1):55-8. Review.

  1. Hepatic steatosis in obese patients: clinical aspects and prognostic significance.

Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G.

Obes Rev. 2004 Feb;5(1):27-42. Review.

  1. Safety of interferon beta treatment for chronic HCV hepatitis.

Festi D, Sandri L, Mazzella G, Roda E, Sacco T, Staniscia T, Capodicasa S, Vestito A, Colecchia A.

World J Gastroenterol. 2004 Jan;10(1):12-6. Review.

  1. Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels.

Brillanti S, Levantesi F, Nigro G, Vicari S, Roda E.

Ann Intern Med. 2003 Dec 2;139(11):W83.

  1. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.

Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland CR, Tognon M, Roda E, Bazzoli F.

Cancer Res. 2003 Nov 1;63(21):7256-62.

  1. Gallbladder motility and functional gastrointestinal disorders.

Colecchia A, Sandri L, Staniscia T, Vestito A, Capodicasa S, Portincasa P, Mazzella G, Roda E, Festi D.

Dig Liver Dis. 2003 Jul;35 Suppl 3:S30-4. Review.

 

  1. Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial.

Jaboli MF, Fabbri C, Liva S, Azzaroli F, Nigro G, Giovanelli S, Ferrara F, Miracolo A, Marchetto S, Montagnani M, Colecchia A, Festi D, Reggiani LB, Roda E, Mazzella G.

World J Gastroenterol. 2003 Jul;9(7):1491-5.

  1. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy.

Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, Liva S, Nigro G, Miracolo A, Festi D, Colecchia A, Montagnani M, Roda E, Mazzella G.

World J Gastroenterol. 2003 Jul;9(7):1487-90.

  1. Diverticular disease of the colon: new perspectives in symptom development and treatment.

Colecchia A, Sandri L, Capodicasa S, Vestito A, Mazzella G, Staniscia T, Roda E, Festi D.

World J Gastroenterol. 2003 Jul;9(7):1385-9. Review.

  1. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance.

Mazzeo C, Azzaroli F, Giovanelli S, Dormi A, Festi D, Colecchia A, Miracolo A, Natale P, Nigro G, Alberti A, Roda E, Mazzella G.

Gut. 2003 Jul;52(7):1030-4.

  1. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer.

Ricciardiello L, Goel A, Mantovani V, Fiorini T, Fossi S, Chang DK, Lunedei V, Pozzato P, Zagari RM, De Luca L, Fuccio L, Martinelli GN, Roda E, Boland CR, Bazzoli F.

Cancer Res. 2003 Feb 15;63(4):787-92.

  1. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.

Simoni P, Sabatini L, Baraldini M, Mirasoli M, Roda A, Roda E.

Int J Clin Pharmacol Res. 2002;22(2):37-45.

  1. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation.

Brillanti S, Vivarelli M, De Ruvo N, Aden AA, Camaggi V, D’Errico A, Furlini G, Bellusci R, Roda E, Cavallari A.

Liver Transpl. 2002 Oct;8(10):884-8.

  1. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.

Roda E, Azzaroli F, Nigro G, Piazza F, Jaboli F, Ferrara F, Liva S, Giovanelli S, Miracolo A, Colecchia A, Festi D, Mazzeo C, Bacchi L, Roda A, Mazzella G.

Dig Liver Dis. 2002 Jul;34(7):523-7.

  1. Chemoprevention in colorectal neoplasias: what is practical and feasible?

Ricciardiello L, Roda E, Bazzoli F.

Dig Dis. 2002;20(1):70-2. Review.

 

  1. Bioavailability of a new ketoprofen formulation for once-daily oral administration.

Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E.

Int J Pharm. 2002 Jul 8;241(1):165-72.

  1. The UDCA dosage deficit: a fate shared with CDCA.

Roda E, Liva S, Ferrara F, Azzaroli F, Giovanelli S, Nigro G, Festi D, Mazzella G.

Eur J Gastroenterol Hepatol. 2002 Mar;14(3):213-6.

  1. Helicobacter pylori and functional dyspepsia: review of previous studies and commentary on new data.

Bazzoli F, De Luca L, Pozzato P, Zagari RM, Fossi S, Ricciardiello L, Nicolini G, Berretti D, Roda E. Gut. 2002 May;50 Suppl 4:iv33-5. Review.

  1. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, De Luca L, Berretti D, Alampi G, Di Pietro C, Morelli P, Roda E.

Aliment Pharmacol Ther. 2002 Jan;16(1):153-8

  1. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates’ protection of liver damage induced by chenodeoxycholic acid.

Piazza F, Montagnani M, Russo C, Azzaroli F, Aldini R, Roda E, Roda A.

Dig Liver Dis. 2000 May;32(4):318-28.

  1. The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors.

Bazzoli F, Palli D, Zagari RM, Festi D, Pozzato P, Nicolini G, Masala G, Fossi S, Ricciardiello L, Panuccio D, Roda E.

Aliment Pharmacol Ther. 2001 Jul;15(7):1001-7.

  1. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

Trevisani F, D’Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M.

J Hepatol. 2001 Apr;34(4):570-5.

  1. Incidence and recurrence rates of colorectal adenomas in first-degree asymptomatic relatives of patients with colon cancer.

Fossi S, Bazzoli F, Ricciardiello L, Nicolini G, Zagari RM, Pozzato P, Palli D, Roda E.

Am J Gastroenterol. 2001 May;96(5):1601-4.

  1. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.

Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E.

Hepatology. 2001 Mar;33(3):504-8. Erratum in: Hepatology 2002 May;35(5):1291. Nicola, R [corrected to Rizzo, N]; Francesco, A [corrected to Azzaroli, F]; Patrizia, S [corrected to Simoni, P]; Luciano, B [corrected to Bovicelli, L]; Anna, M [corrected to Miracolo, A]; Giuliana, S [corrected to Simonazzi, G]; Antonio, C [corrected to Colecchia, A]; Giovanni, N [corrected to Nigro, G]; Constance, M [corrected to Mwangemi, C]; Davide, F [corrected to Festi, D]; Enrico, R [corrected to Roda, E].

 

  1. Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente.

Portincasa P, Colecchia A, Di Ciaula A, Larocca A, Muraca M, Palasciano G, Roda E, Festi D.

Dig Liver Dis. 2000 Mar;32(2):160-72.

  1. Severe acute gastritis associated with Helicobacter pylori infection.

Caletti G, Fusaroli P, Tucci A, Fedrigo M, Bettini G, Roda E.

Dig Liver Dis. 2000 Jan-Feb;32(1):34-8.

  1. Review: low caloric intake and gall-bladder motor function.

Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, Romano F, Roda E.

Aliment Pharmacol Ther. 2000 May;14 Suppl 2:51-3. Review.

  1. Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients.

Fabbri C, Marchetto S, Pezzoli A, Accogli E, Fusaroli P, Azzaroli F, Jaboli MF, Mazzeo C, Montagnani M, Festi D, Roda E, Mazzella G.

Eur J Gastroenterol Hepatol. 2000 May;12(5):511-5.

  1. Helicobacter pylori: optimum diagnosis and test of cure.

Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, De Luca L, Nicolini G, Berretti D, Maltoni S, Gorini B, Martuzzi C, Fuccio L, Roda E.

J Chemother. 1999 Dec;11(6):601-5. Review.

  1. Endosonography in gastric lymphoma and large gastric folds.

Caletti G, Fusaroli P, Togliani T, Bocus P, Roda E.

Eur J Ultrasound. 2000 Mar;11(1):31-40

  1. Validation of the 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a multicenter study.

Bazzoli F, Cecchini L, Corvaglia L, Dall’Antonia M, De Giacomo C, Fossi S, Casali LG, Gullini S, Lazzari R, Leggeri G, Lerro P, Valdambrini V, Mandrioli G, Marani M, Martelli P, Miano A, Nicolini G, Oderda G, Pazzi P, Pozzato P, Ricciardiello L, Roda E, Simoni P, Sottili S, Zagari RM.

Am J Gastroenterol. 2000 Mar;95(3):646-50.

  1. Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Mazzella G, Fusaroli P, Pezzoli A, Azzaroli F, Mazzeo C, Zambonin L, Simoni P, Festi D, Roda E.

Dig Dis Sci. 1999 Dec;44(12):2478-83

  1. Evolving concepts in the pathophysiology of biliary lipid secretion.

Carrella M, Roda E.

Ital J Gastroenterol Hepatol. 1999 Oct;31(7):643-8. Review.

 

  1. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL).

Festi D, Sottili S, Colecchia A, Attili A, Mazzella G, Roda E, Romano F.

Hepatology. 1999 Oct;30(4):839-46.

  1. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.

Azzaroli F, Mazzella G, Mazzeo C, Simoni P, Festi D, Colecchia A, Montagnani M, Martino C, Villanova N, Roda A, Roda E.

Am J Gastroenterol. 1999 Sep;94(9):2453-9.

  1. Review article: non-invasive methods for the diagnosis of Helicobacter pylori infection.

Zagari RM, Bazzoli F, Pozzato P, Fossi S, De Luca L, Nicolini G, Berretti D, Roda E.

Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):408-15. Review.

  1. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial.

Mazzella G, Saracco G, Festi D, Rosina F, Marchetto S, Jaboli F, Sostegni R, Pezzoli A, Azzaroli F, Cancellieri C, Montagnani M, Roda E, Rizzetto M.

Am J Gastroenterol. 1999 Aug;94(8):2246-50.

  1. Diagnosis of Helicobacter pylori infection: non-invasive diagnostic tests.

Bazzoli F, Zagari M, Pozzato P, Fossi S, Ricciardiello GL, Nicolini G, De Luca L, Berretti D, Maltoni S, Martuzzi C, Roda E.

Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S313-4.

  1. Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patients.

Zinzani PL, Colecchia A, Festi D, Magagnoli M, Larocca A, Ascani S, Bendandi M, Orcioni GF, Gherlinzoni F, Albertini P, Pileri SA, Roda E, Tura S.

Haematologica. 1998 Nov;83(11):989-92.

  1. New insights in the physiology and molecular basis of the intestinal bile acid absorption.

Montagnani M, Aldini R, Roda A, Roda E.

Ital J Gastroenterol Hepatol. 1998 Aug;30(4):435-40. Review.

  1. Development of a chemiluminescent urease activity assay for Helicobacter pylori infection diagnosis in gastric mucosa biopsies.

Roda A, Piazza F, Pasini P, Baraldini M, Zambonin L, Fossi S, Bazzoli F, Roda E.

Anal Biochem. 1998 Nov 1;264(1):47-52.

  1. Cancer of the esophagus–endoscopic ultrasound: selection for cure.

Caletti G, Bocus P, Fusaroli P, Togliani T, Marhefka G, Roda E.

Can J Gastroenterol. 1998 Jul-Aug;12(5):341-6. Review.

  1. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.

Ricciardiello L, Cannizzaro O, D’Angelo A, Ederle A, Gerace G, Iaquinto G, Reina G, Scarpulla G, Spadaccini A, Olivieri A, Tosatto R, Fossi S, Pozzato P, Zagari M, Bazzoli F, Roda E.

Aliment Pharmacol Ther. 1998 Jun;12(6):533-7.

 

  1. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well).

Festi D, Colecchia A, Orsini M, Sangermano A, Sottili S, Simoni P, Mazzella G, Villanova N, Bazzoli F, Lapenna D, Petroni ML, Pavesi S, Neri M, Roda E.

Int J Obes Relat Metab Disord. 1998 Jun;22(6):592-600.

  1. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.

Pozzato P, Zagari M, Cardelli A, Catalano FA, Giglio A, Lami F, Pilotto A, Scarpulla G, Spadaccini A, Susi D, Tosatto R, Olivieri A, Bazzoli F, Roda E.

Aliment Pharmacol Ther. 1998 May;12(5):447-51.

  1. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.

Bazzoli F, Zagari M, Pozzato P, Varoli O, Fossi S, Ricciardiello L, Alampi G, Nicolini G, Sottili S, Simoni P, Roda A, Roda E.

Aliment Pharmacol Ther. 1998 May;12(5):439-45.

  1. Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey.

Hellstern A, Leuschner U, Benjaminov A, Ackermann H, Heine T, Festi D, Orsini M, Roda E,

Northfield TC, Jazrawi R, Kurtz W, Schmeck-Lindenau HJ, Stumpf J, Eidsvoll BE, Aadland E,

Lux G, Boehnke E, Wurbs D, Delhaye M, Cremer M, Sinn I, Höring E, v Gaisberg U, Neubrand

M, Paul F, et al.

Dig Dis Sci. 1998 May;43(5):911-20. Erratum in: Dig Dis Sci 1998 Nov;43(11):2572.

  1. Determination of fecal fat concentration by near infrared spectrometry for the screening of pancreatic steatorrhea.

Ventrucci M, Cipolla A, Di Stefano M, Ubalducci GM, Middonno M, Ligabue A, Roda E.

Int J Pancreatol. 1998 Feb;23(1):17-23.

  1. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency.

Ventrucci M, Cipolla A, Ubalducci GM, Roda A, Roda E.

Gut. 1998 Jan;42(1):81-7.

  1. Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats.

Gasbarrini A, Pasini P, Nardo B, De Notariis S, Simoncini M, Cavallari A, Roda E, Bernardi M, Roda A.

Free Radic Biol Med. 1998 Jan 15;24(2):211-6.

  1. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian

Study on Epidemiology of Cholelithiasis.

Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, Menotti A, Okolicsanyi L, Ricci G, Lalloni L, Mariotti S, Sama C, Scafato E.

Hepatology. 1997 Oct;26(4):809-18.

  1. Urea breath tests for the detection of Helicobacter pylori infection.

Bazzoli F, Zagari M, Fossi S, Pozzato P, Ricciardiello L, Mwangemi C, Roda A, Roda E.

Helicobacter. 1997 Jul;2 Suppl 1:S34-7. Review.

  1. Update on Helicobacter pylori research. Dyspepsia.

Malfertheiner P, McColl K, Baldi F, Dinelli M, Festi D, Parente F, Ricciardiello L, Roda E, Scarpulla G, Stanghellini V, Torre G.

Eur J Gastroenterol Hepatol. 1997 Jun;9(6):624-5.

  1. [Intrahepatic cholestasis in chronic liver disease]

Roda E, Pezzoli A, Fusaroli P, Fabbri C, Jaboli F, Marchetto S, Azzaroli F, Mazzella G.

Ann Ital Med Int. 1996 Oct;11 Suppl 2:48S-52S. Review.

  1. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification.

Aldini R, Roda A, Montagnani M, Cerrè C, Pellicciari R, Roda E.

Steroids. 1996 Oct;61(10):590-7.

  1. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E.

J Hepatol. 1996 Feb;24(2):141-7.

  1. Species differences in hepatic bile acid uptake: comparative evaluation of taurocholate and tauroursodeoxycholate extraction in rat and rabbit.

Montagnani M, Aldini R, Roda A, Caruso ML, Gioacchini AM, Lenzi PL, Roda E.

Comp Biochem Physiol A Physiol. 1996 Feb;113(2):157-64.

  1. Intestinal absorption of bile acids in the rabbit: different transport rates in jejunum and ileum.

Aldini R, Montagnani M, Roda A, Hrelia S, Biagi PL, Roda E.

Gastroenterology. 1996 Feb;110(2):459-68.

  1. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.

Mazzella G, Cipolla A, Villanova N, Polimeni C, Sipahi A, Parini P, Fusaroli P, Festi D, Roda E.

Ital J Gastroenterol. 1995 Oct-Nov;27(8):441-5.

  1. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer.

Bazzoli F, Fossi S, Sottili S, Pozzato P, Zagari RM, Morelli MC, Taroni F, Roda E.

Gastroenterology. 1995 Sep;109(3):783-8.

  1. Bile acid structure and intestinal absorption in the animal model.

Aldini R, Roda A, Montagnani M, Roda E.

Ital J Gastroenterol. 1995 Apr;27(3):141-4. Review.

  1. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation.

Simoni P, Cerrè C, Cipolla A, Polimeni C, Pistillo A, Ceschel G, Roda E, Roda A.

Pharmacol Res. 1995 Feb;31(2):115-9.

  1. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)

Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, Okoliksanyi L, Ricci G, Capocaccia R, Festi D, et al.

Am J Epidemiol. 1995 Jan 15;141(2):158-65.

  1. Nutritional status affects the sensitivity to anoxia/reoxygenation in hepatocytes.

Gasbarrini A, Caraceni P, Colantoni A, De Notariis S, Van Thiel DH, Roda E, Facchini A, Gasbarrini G, Bernardi M.

Transplant Proc. 1994 Dec;26(6):3408-9. No abstract available

  1. Hepatic uptake and intestinal absorption of bile acids in the rabbit.

Aldini R, Roda A, Montagnani M, Polimeni C, Lenzi PL, Cerre C, Galletti G, Roda E.

Eur J Clin Invest. 1994 Oct;24(10):691-7.

  1. [Consensus conference: therapy and prevention of biliary lithiasis]

Barbara L, Roda E, Malavolti M, Sama C, Morselli Labate AM, Zamboni L, Cicognani C.

Minerva Med. 1994 Jun;85(6):343-8. Review. Italian.

  1. Improved intestinal absorption of an enteric-coated sodium ursodeoxycholate formulation.

Roda A, Roda E, Marchi E, Simoni P, Cerrè C, Pistillo A, Polimeni C.

Pharm Res. 1994 May;11(5):642-7.

  1. Evaluation of the effect of rifaximin in colon diverticular disease by means of lactulose hydrogen breath test.

Ventrucci M, Ferrieri A, Bergami R, Roda E.

Curr Med Res Opin. 1994;13(4):202-6.

  1. Influence of ursodeoxycholic acid on biliary lipids.

Roda E, Cipolla A, Salzetta A, Marchetto S, Pezzoli A, Accogli E, Novelli V, Polimeni C, Cerrè C, Mazzella G.

Scand J Gastroenterol Suppl. 1994;204:16-8. Review.

  1. Pseudotumoral appearance of a duodenal diverticulum by ultrasonography: a case report.

Li Bassi S, Morelli MC, Belluzzi A, Polifemo AM, Cappello I, Roda E.

J Ultrasound Med. 1993 Nov;12(11):694-6. No abstract available.

  1. Treatment of hepatic encephalopathy with non-absorbable antibiotics.

Festi D, Mazzella G, Parini P, Ronchi M, Cipolla A, Orsini M, Sangermano A, Bazzoli F, Aldini R, Roda E.

Ital J Gastroenterol. 1992 Nov-Dec;24(9 Suppl 2):14-6. Review.

  1. Urea breath tests for the detection of Helicobacter pylori infection.

Bazzoli F, Zagari M, Fossi S, Pozzato P, Ricciardiello L, Mwangemi C, Roda A, Roda E.

Helicobacter. 1997 Jul;2 Suppl 1:S34-7. Review.

  1. Update on Helicobacter pylori research. Dyspepsia.

Malfertheiner P, McColl K, Baldi F, Dinelli M, Festi D, Parente F, Ricciardiello L, Roda E, Scarpulla G, Stanghellini V, Torre G.

Eur J Gastroenterol Hepatol. 1997 Jun;9(6):624-5.

 

 

  1. [Intrahepatic cholestasis in chronic liver disease]

Roda E, Pezzoli A, Fusaroli P, Fabbri C, Jaboli F, Marchetto S, Azzaroli F, Mazzella G.

Ann Ital Med Int. 1996 Oct;11 Suppl 2:48S-52S. Review. Italian.

  1. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification.

Aldini R, Roda A, Montagnani M, Cerrè C, Pellicciari R, Roda E.

Steroids. 1996 Oct;61(10):590-7.

  1. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E.

J Hepatol. 1996 Feb;24(2):141-7.

  1. Species differences in hepatic bile acid uptake: comparative evaluation of taurocholate and tauroursodeoxycholate extraction in rat and rabbit.

Montagnani M, Aldini R, Roda A, Caruso ML, Gioacchini AM, Lenzi PL, Roda E.

Comp Biochem Physiol A Physiol. 1996 Feb;113(2):157-64.

  1. Intestinal absorption of bile acids in the rabbit: different transport rates in jejunum and ileum.

Aldini R, Montagnani M, Roda A, Hrelia S, Biagi PL, Roda E.

Gastroenterology. 1996 Feb;110(2):459-68.

  1. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.

Mazzella G, Cipolla A, Villanova N, Polimeni C, Sipahi A, Parini P, Fusaroli P, Festi D, Roda E.

Ital J Gastroenterol. 1995 Oct-Nov;27(8):441-5.

  1. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer.

Bazzoli F, Fossi S, Sottili S, Pozzato P, Zagari RM, Morelli MC, Taroni F, Roda E.

Gastroenterology. 1995 Sep;109(3):783-8.

  1. Bile acid structure and intestinal absorption in the animal model.

Aldini R, Roda A, Montagnani M, Roda E.

Ital J Gastroenterol. 1995 Apr;27(3):141-4. Review.

  1. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia.

Mazzella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D, Cipolla A, Salzetta A, Roda E.

Hepatology. 1992 Jun;15(6):1072-8.

  1. [Effects of therapy with bis-hemisuccinate of ursodeoxycholic acid bisodium salt in patients with chronic hepatitis]

Pinto A, Parini P, Novelli V, Zagari M, Sangermano A, Orsini M, Salzetta A, Buffarini F, Roda E.

Minerva Med. 1992 Jun;83(6):359-61.

  1. [Alpha-interferon therapy: an echographic study of left ventricular function and a clinical assessment of cardiovascular complications]

Tarquinii M, Lolli C, Foscoli M, Pinto A, Mazzella G, Labriola E, Roda E, Toschi GP.

Ann Ital Med Int. 1992 Apr-Jun;7(2):84-6.

  1. Advances in the therapy of cholestatic liver disease.

Roda E, Parini P, Bazzoli F, Mazzella G, Festi D, Aldini R.

Hepatogastroenterology. 1992 Feb;39 Suppl 1:53-5. Review. available.

  1. Hepatic uptake and biliary secretion of bile acids in the perfused rat liver.

Aldini R, Roda A, Lenzi P, Calcaterra D, Vaccari C, Calzolari M, Festi D, Mazzella G, Bazzoli F, Roda E, et al.

Pharmacol Res. 1992 Jan;25(1):51-61.

  1. Pathophysiology and pharmacotherapy of cholelithiasis.

Roda E, Aldini R, Bazzoli F, Festi D, Mazzella G, Roda A.

Pharmacol Ther. 1992;53(2):167-85. Review.

  1. Management of intrahepatic cholestasis in pregnancy.

Mazzella G, Rizzo N, Salzetta A, Iampieri R, Bovicelli L, Roda E.

Lancet. 1991 Dec 21-28;338(8782-8783):1594-5.

  1. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.

Mazzella G, Bazzoli F, Festi D, Ronchi M, Aldini R, Roda A, Grigolo B, Simoni P, Villanova N, Roda E.

Gastroenterology. 1991 Aug;101(2):490-6

  1. Bile and biliary lipid secretion in rats with hexachlorobenzene-induced porphyria. Effect of S-adenosyl-L-methionine administration.

Cuomo R, Rodino S, Rizzoli R, Simoni P, Roda E, Cantoni L, Rizzardini M, De Rosa G, Le Grazie C, Di Padova C, et al.

J Hepatol. 1991 Jan;12(1):87-93.

  1. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.

Mazzella G, Bazzoli F, Villanova N, Simoni P, Festi D, Roda A, Aldini R, Roda E.

Scand J Gastroenterol. 1990 Dec;25(12):1227-34.

  1. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids.

Senior JR, Johnson MF, DeTurck DM, Bazzoli F, Roda E.

Gastroenterology. 1990 Jul;99(1):243-51

  1. Evaluation of the ileal absorption capacity for bile acids in the rabbit.

Aldini R, Ussia G, Roda A, Grilli Cilioni C, Rizzoli R, Calcaterra D, Roda E, Casanova S, Lenzi P, Festi D, et al.

Eur Surg Res. 1990;22(2):93-100.

  1. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.

Roda E, Mazzella G, Bazzoli F, Villanova N, Minutello A, Simoni P, Ronchi M, Poggi C, Festi D, Aldini R, et al.

Dig Dis Sci. 1989 Dec;34(12 Suppl):52S-58S.

  1. Uptake of bile acids by perfused rat liver: evidence of a structure-activity relationship.

Aldini R, Roda A, Simoni P, Lenzi P, Roda E.

Hepatology. 1989 Nov;10(5):840-5.

  1. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment.

Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, Barbara L, Roda E.

Gastroenterology. 1989 Sep;97(3):726-31.

  1. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.

Mazzella G, Villanova N, Amed MA, Barbara L, Saracco G, Rizzetto M, Cancellieri C, Roda E.

J Chemother. 1989 Jul;1(4 Suppl):1094-5.

  1. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.

Mazzella G, Villanova N, Abdu-Ahmed M, Barbara L, Saracco G, Rizzetto M, Cancellieri C, Roda E.

Chemioterapia. 1988 Dec;7 Suppl 3:12-4.

  1. 23-Methyl-3 alpha,7 beta-dihydroxy-5 beta-cholan-24-oic acid: dose-response study of biliary secretion in rat.

Roda A, Aldini R, Grigolo B, Simoni P, Roda E, Pellicciari R, Lenzi PL, Natalini B.

Hepatology. 1988 Nov-Dec;8(6):1571-6.

  1. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.

Mazzella G, Saracco G, Rizetto M, Amed MA, Gonzàlez Quintela A, Rosina F, Barbara L, Roda E.

Am J Med. 1988 Aug 29;85(2A):141-2.

  1. Quantitative relationship between bile acid structure and biliary lipid secretion in rats.

Roda A, Grigolo B, Roda E, Simoni P, Pellicciari R, Natalini B, Fini A, Labate AM.

J Pharm Sci. 1988 Jul;77(7):596-605.

  1. Oral bile acid treatment for cholesterol gallstones.

Roda E, Bazzoli F, Mazzella G, Festi D, Villanova N, Ronchi M.

Acta Gastroenterol Belg. 1988 May-Jun;51(3):244-9. Review.

  1. A population study on the prevalence of gallstone disease: the Sirmione Study.

Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, Sapio C, Roda E, Banterle C, Puci A, et al.

Hepatology. 1987 Sep-Oct;7(5):913-7.

  1. Role of albumin in liver uptake.

Roda E, Aldini R, Roda A.

Gastroenterology. 1987 Apr;92(4):1097.

  1. Effect of albumin on taurocholate uptake kinetics in rat liver.

Aldini R, Roda A, Morselli-Labate AM, Simoni P, Roda E, Barbara L.

Clin Sci (Lond). 1987 Jan;72(1):11-7.

  1. Treatment of chronic B virus hepatitis with specific transfer factor.

Mazzella G, Ronchi M, Villanova N, Mohamed AA, Pizza G, De Vinci C, Viza D, Roda E, Barbara L.

J Exp Pathol. 1987 Summer;3(4):421-3. No abstract available.

  1. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.

Barbara L, Mazzella G, Baraldini M, Gasbarrini G, Giungi F, Malavolti M, Mastroroberto L, Miglio F, Roda E, Raise E, et al.

J Hepatol. 1986;3 Suppl 2:S235-8. No abstract available.

  1. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.

Bazzoli F, Fromm H, Roda A, Tunuguntla AK, Roda E, Barbara L, Amin P.

Dig Dis Sci. 1985 Jul;30(7):650-4.

  1. Transfer factor for the treatment of HBsAg-positive chronic active hepatitis.

Roda E, Viza D, Pizza G, Mastroroberto L, Phillips J, De Vinci C, Barbara L.

Proc Soc Exp Biol Med. 1985 Mar;178(3):468-75.

  1. Correlation between fetal and maternal serum bile acid concentrations.

Colombo C, Roda A, Roda E, Buscaglia M, dell’Agnola CA, Filippetti P, Ronchi M, Sereni F.

Pediatr Res. 1985 Feb;19(2):227-31

  1. Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency.

Colombo C, Roda A, Roda E, Piceni Sereni L, Brega A, Fugazza R, Giunta A.

J Pediatr Gastroenterol Nutr. 1984 Sep;3(4):556-62.

  1. Diagnostic effectiveness of serum bile acids in liver diseases as evaluated by multivariate statistical methods.

Festi D, Morselli Labate AM, Roda A, Bazzoli F, Frabboni R, Rucci P, Taroni F, Aldini R, Roda E, Barbara L.

Hepatology. 1983 Sep-Oct;3(5):707-13.

  1. Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.

Colombo C, Roda A, Roda E, Piceni Sereni L, Maspero D, Giunta AM, Barbara L.

Dig Dis Sci. 1983 Apr;28(4):306-11.PMID: 6831994 [PubMed - indexed for MEDLINE]Related articles

  1. A double-blind comparative trial of dihydroxydibutylether in patients with cholesterol gallstones.

Sama C, Petronelli A, Malavolti M, Mastroroberto G, Roda E.

Int J Clin Pharmacol Ther Toxicol. 1983 Feb;21(2):95-7.

  1. Treatment of constipation with chenodeoxycholic acid.

Bazzoli F, Malavolti M, Petronelli A, Barbara L, Roda E.

J Int Med Res. 1983;11(2):120-3.

  1. Hepatic bile acid uptake: effect of conjugation, hydroxyl and keto groups, and albumin binding.

Aldini R, Roda A, Labate AM, Cappelleri G, Roda E, Barbara L.

J Lipid Res. 1982 Nov;23(8):1167-73.

  1. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.

Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L.

Hepatology. 1982 Nov-Dec;2(6):804-10.

  1. Diagnostic value of serum primary bile acids in detecting bile acid malabsorption.

Aldini R, Roda A, Festi D, Mazzella G, Morselli AM, Sama C, Roda E, Scopinaro N, Barbara L.

Gut. 1982 Oct;23(10):829-34.

  1. Bile acid malabsorption and bile acid diarrhea in intestinal resection.

Aldini R, Roda A, Festi D, Sama C, Mazzella G, Bazzoli F, Morselli AM, Roda E, Barbara L.

Dig Dis Sci. 1982 Jun;27(6):495-502.

  1. Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey.

Bazzoli F, Roda A, Fromm H, Sarva RP, Roda E, Barbara L.

Dig Dis Sci. 1982 May;27(5):417-24.

  1. Serum primary bile acids in Gilbert’s syndrome.

Roda A, Roda E, Sama C, Festi D, Aldini R, Morselli AM, Mazzella G, Barbara L.

Gastroenterology. 1982 Jan;82(1):77-83.

  1. [Effect of the administration of silymarin on serum lipid levels]

Petronelli A, Roda E, Briganti M, Morselli Labate AM, Barbara L.

Clin Ter. 1981 Dec 15;99(5):471-82.

  1. Effect of chenodiol on the small intestine. Unimpaired structure and function during therapy for gallstone dissolution.

Casanova S, Roda A, Festi D, Mazzella G, Aldini R, Bazzoli F, Sama C, Morselli AM, Barbara L, Roda E.

JAMA. 1981 Dec 4;246(22):2597-601

  1. Effects of a salt of cholestyramine and 2-[4-(p-chlorobenzoyl)phenoxy]2-methyl propionic acid (alpha-1081) on biliary lipid secretion in rats.

Aldini R, Barbara L, Benelli A, Borzatta V, Geminiani S, Mascellani G, Morselli A, Roda A, Roda E.

Br J Pharmacol. 1981 Nov;74(3):611-7.

  1. [Percutaneous transhepatic cholangiography and percutaneous transhepatic drainage in diagnosis and palliative treatment of obstructive jaundice (author's transl)]

Roversi R, Bazzocchi R, Roda E, Rossi C, Pagano F, Cordinaldesi A.

Radiol Med. 1981 Jan-Feb;67(1-2):31-42. Italian.

  1. Serum bile acids in newborns and children.

Barbara L, Lazzari R, Roda A, Aldini R, Festi D, Sama C, Morselli AM, Collina A, Bazzoli F, Mazzella G, Roda E.

Pediatr Res. 1980 Nov;14(11):1222-5.

  1. Results with six “kit” radioimmunoassays for primary bile acids in human serum intercompared.

Roda A, Roda E, Aldini R, Capelli M, Festi D, Sama C, Mazzella G, Morselli AM, Barbara L.

Clin Chem. 1980 Nov;26(12):1677-82.

  1. [Problems of physiopathology of the enterohepatic circulation of bile acids. The "colonopathies"]

Barbara L, Roda E, Sama C, Festi D, Mazzella G, Aldini R, Roda A.

Minerva Med. 1980 Jan 14;71(1):33-6.

  1. [Determinants of serum levels of biliary acids]

Roda E, Roda A, Mazzella G, Aldini R, Sama C, Festi D, Barbara L.

Minerva Med. 1979 Dec 22;70(57):3907-10.

  1. Effect of cycloxilic acid administration on ethanol-induced hepatic steatosis. Controlled clinical trial.

Geminiani S, Mazella G, Aldini R, Bazzoli F, Morselli AM, Rossi R, Zappi A, Roda E.

Farmaco Prat. 1979 Oct;34(10):449-55.

  1. [Kinetics of 14C-cholic acid in the baboon under normal conditions and in cholestasis. Description and validity of a multicompartmental model]

Morselli AM, Roda E, Roda A, Sama C, Aldini R, Mazzella G, Festi D, Bazzoli F, Sarti E, Barbara L.

Boll Soc Ital Biol Sper. 1979 Aug 15;55(15):1527-33.

  1. [Controlled clinical evaluation of the therapeutic effectiveness of AICA orotate in chronic hepatitis]

Roda E, Sama C, Festi D.

Clin Ter. 1979 Jun 15;89(5):489-93. Italian. No abstract available.

  1. Transfer factor for the treatment of chronic acute hepatitis.

Pizza G, Viza D, Roda A, Aldini R, Roda E, Barbara L.

N Engl J Med. 1979 Jun 7;300(23):1332. No abstract available.

  1. Caroli’s disease. description of a rare clinical case with monolobar localization.

Roda E, Sama C, Festi D, Aldini R, Mazzella G, Roda A, Barbara L.

Am J Gastroenterol. 1979 Jun;71(6):621-6.

  1. .Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.

Roda E, Roda A, Sama C, Festi D, Mazzella G, Aldini R, Barbara L.

Dig Dis Sci. 1979 Feb;24(2):123-8.

  1. [Radioimmunoassay for biliary acids: its value in diagnosis and prognosis (author's transl)]

Roda A, Roda E, Festi D, Sama C, Mazzella G, Aldini R, Barbara L.

Acta Gastroenterol Belg. 1978 Nov-Dec;41(11-12):653-8.

  1. Effect of cicloxilic acid on biliary lipid output in man.

Sama C, Festi D, Aldini R, Mazzella C, Roda A, Bazzoli F, Roda E.

Farmaco Prat. 1978 Aug;33(8):371-8.

  1. A radioimmunoassay for lithocholic acid conjugates in human serum and liver tissue.

Roda A, Roda E, Festi D, Aldini R, Mazzella G, Sama C, Barbara L.

Steroids. 1978 Jul-Aug;32(1):13-24.PMID

  1. Enterohepatic circulation of bile acids after cholecystectomy.

Roda E, Aldini R, Mazzella

  1. Pseudotumoral appearance of a duodenal diverticulum by ultrasonography: a case report.

Li Bassi S, Morelli MC, Belluzzi A, Polifemo AM, Cappello I, Roda E.

J Ultrasound Med. 1993 Nov;12(11):694-6. No abstract available.

  1. Treatment of hepatic encephalopathy with non-absorbable antibiotics.

Festi D, Mazzella G, Parini P, Ronchi M, Cipolla A, Orsini M, Sangermano A, Bazzoli F, Aldini R, Roda E.

Ital J Gastroenterol. 1992 Nov-Dec;24(9 Suppl 2):14-6. Review.

  1. Human transfer factor produced in vitro increases antibody titers in rabbits.

Roda A, Roda E, Pizza G, Boucheix C.

N Engl J Med. 1978 Mar 16;298(11):629.

  1. [Chenodeoxycholic acid therapy of choledochal lithiasis]

Barbara L, Roda E, Sassi P, Festi D, Sama C, Aldini R, Mazzella G, Roda A.

Minerva Dietol Gastroenterol. 1978 Jan-Mar;24(1):13-23.

  1. Determination of 14CO2 in breath and 14C in stool after oral administration of cholyl-1- [14C]glycine: clinical application.

Roda A, Roda E, Aldini R, Mazzella G, Festi D, Sama C, Barbara L.

Clin Chem. 1977 Nov;23(11):2127-32

  1. Development, validation, and application of a single-tube radioimmunoassay for cholic and

chenodeoxycholic conjugated bile acids in human serum.

Roda A, Roda E, Aldini R, Festi D, Mazzella G, Sama C, Barbara L.

Clin Chem. 1977 Nov;23(11):2107-13.

  1. [Medical treatment of cholesterol cholelithiasis using chemodeoxycholic acid in man]

Barbara L, Roda E, Roda A, Casanova S, Festi D, Sama C, Mazella G, Aldini R.

Minerva Med. 1977 Oct 17;68(49):3355-82.

  1. [Correlation of malabsorption of bile acids, bile lipid composition and calculi]

Barbara L, Sama C, Roda A, Festi D, Mazzella G, Aldini R, Roda E.

Minerva Med. 1977 Sep 19;68(43):3031-6.

  1. [Results of chenic acid therapy in patients with cholesterol calculi]

Roda E, Festi D, Roda A, Sama C, Aldini R, Mazzella G.

Minerva Med. 1977 Sep 19;68(43):3027-9.

  1. [Changes in bile and blood lipid levels following chenodeoxycholic acid therapy]

Barbara L, Roda A, Sama C, Festi D, Mazzella G, Aldini R, Sorci F, Roda E.

Minerva Med. 1977 Sep 19;68(43):3023-6.

  1. A radioimmunoassay of primary bile acid conjugates in human serum.

Roda A, Roda E, Festi D, Sama C, Mazzella G, Aldini R, Barbara L.

Ric Clin Lab. 1977 Apr-Jun;7(2):163-78.

  1. [Pathogenetic aspects of biliary lithiasis as a complication of jejuno-ileal shunt]

Scopinaro N, Roda E, Gianetta E.

Minerva Chir. 1976 May 31;31(10):567-72.

  1. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.

Barbara L, Roda E, Roda A, Sama C, Festi D, Mazzella G, Aldini R.

Digestion. 1976;14(3):209-19.

  1. Enzymatic determination of cholesterol in bile.

Roda A, Festi D, Sama C, Mazzella G, Alini R, Roda E, Barbara L.

Clin Chim Acta. 1975 Nov 3;64(3):337-41.

  1. [Aneurysms of distal anterior cerebral artery (author's transl)]

Villarejo FJ, Hernando C, Roda E.

Rev Esp Otoneurooftalmol Neurocir. 1975 Nov-Dec;33(196):229-36.

  1. [Therapy of cholesterol lithiasis with chenodeoxycholic acid (Chenoxyl)]

Barbara L, Roda E, Roda A, Festi D, Sama C, Mazzella G, Aldini R, Labò G.

Minerva Med. 1975 Feb 17;66(12):562-9. Italian.

  1. [Carotid cavernous fistulas (author's transl)]

Obrador S, Gómez Bueno J, Roda E, Soto M.

Rev Esp Otoneurooftalmol Neurocir. 1973 Jul-Aug;31(182):197-217.

  1. [ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis]

Labò G, Barbara L, Gasbarrini G, Roda E, Schiavina M, Bonvicini F.

Minerva Med. 1972 Oct 24;63(75):4055-9

  1. Ultrastructural aspects of the liver in cases of constitutional non haemolytic hyperbilirubinemia before and after treatment with barbiturates. Morphological aspects of enzymatic induction.

Labò G, Gasbarrini G, Miglio F, Roda E, Bernardi M.

Acta Vitaminol Enzymol. 1972;26(5):149-62.

  1. [Stomach peroral biopsy in the diagnosis of chronic gastritis]

Gasbarrini G, Miglio F, Roda E, Randi V, Schiavina M, Fini M.

Bull Sci Med (Bologna). 1971 Oct-Dec;143(4):314-23

  1. [Diagnostic value of small intestine biopsy in primary and secondary malabsorption syndromes]

Gasbarrini G, Miglio F, Roda E, Vignoli GC.

Bull Sci Med (Bologna). 1971 Oct-Dec;143(4):285-6.

  1. [Stomach biopsy in non-neoplastic diseases]

Gasbarrini G, Miglio F, Freyrie V, Roda E.

Bull Sci Med (Bologna). 1970 Apr-Jun;142(2):201-13.

 


Società scientifiche
Visita specialistica

About Enrico Roda

Negli anni immediatamente successivi alla laurea in Medicina e Chirurgia conseguita presso l’Università di Bologna nel 1966, il Prof. Enrico Roda ha svolto intensa attività di ricerca e di insegnamento presso la Facoltà di Medicina e Chirurgia dell’Universita’ di Bologna. In particolare il settore che più lo ha qualificato in campo nazionale ed internazionale e’ stata la fisiologia e la patologia degli acidi biliari che ha dato fecondi risultati pratici portando alla messa a punto di nuove terapie della calcolosi biliare di colesterolo. Oltre alla sua attività di insegnamento come Docente del corso integrato di Malattie dell’Apparato Digerente presso la Facoltà di Medicina e Chirurgia dell’Università di Bologna, attualmente il Prof. Enrico Roda e’ Responsabile della U.O. di Gastroenterologia del Policlinico S. Orsola – Malpighi, Titolare della Cattedra di Gastroenterologia dell’Università di Bologna.

» has written 17 posts

No Comments

You must be logged in to post a comment.

Recapiti attività professionale

Via Del Cane 7 40124 Bologna
Tel.: 051.582737
PRENOTAZIONE VISITA

Visualizzazione ingrandita della mappa